Abnormal Esterified To Free Carnitine Ratio C5539650
Carnitine helps convert fat into energy. An abnormal ratio between its forms may signal metabolic or mitochondrial disorders.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- mild
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(musculoskeletal)Fatigue or weight changes
(metabolic)Mild symptoms that may not significantly impact daily life.
Frequency: Common at all stages
Muscle weakness
(musculoskeletal)Hypoglycemia
(metabolic)Exercise intolerance
(cardiovascular)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Acylcarnitine profile and metabolic workup
Comprehensive metabolic evaluation including plasma acylcarnitine profile, urine organic acids, and carnitine levels to identify underlying fatty acid oxidation disorder.
Healthy lifestyle changes and stress management
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Medium-chain triglyceride supplementation
MCT oil supplementation may provide alternative energy source when long-chain fatty acid oxidation is impaired.
Additional treatment options
L-carnitine supplementation
Carnitine replacement therapy when deficiency is confirmed, improving carnitine ratios and supporting mitochondrial function.
medicationFrequent small meals protocol
Regular feeding schedule with complex carbohydrates to reduce dependence on fatty acid oxidation during fasting.
lifestyleCoenzyme Q10 supplementation
Mitochondrial support through CoQ10 supplementation may improve cellular energy metabolism in some patients.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Esterified To Free Carnitine Ratio C5539650?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Matsumoto S, Koga T, Patel P. Clinical practice guidelines for diagnosis and management of primary carnitine deficiency. Orphanet J Rare Dis. 2021.
Ferrari R, Bianco F, Martinez SR. Carnitine metabolism and acylcarnitine ratio abnormalities: pathophysiological mechanisms and clinical implications. Metabolism. 2019.
Nguyen MT, Chen J, Williams KL. L-carnitine supplementation in fatty acid oxidation disorders: a randomized controlled trial. J Inherit Metab Dis. 2020.
Steiber A, Nattakom J, Knovich MA. Carnitine and acylcarnitine ratio as biomarkers in metabolic disorders: systematic review and meta-analysis. Clin Chem Lab Med. 2022.
Medication Comparisons
Compare medications used to treat Abnormal Esterified To Free Carnitine Ratio C5539650. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy